TrialBritish journal of haematology2008

Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria.

Jörg Schubert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.